RaySearch Laboratories AB (publ) (RAY-B) - Total Assets
Based on the latest financial reports, RaySearch Laboratories AB (publ) (RAY-B) holds total assets worth Skr2.03 Billion SEK (≈ $218.20 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check RAY-B total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
RaySearch Laboratories AB (publ) - Total Assets Trend (2003–2025)
This chart illustrates how RaySearch Laboratories AB (publ)'s total assets have evolved over time, based on quarterly financial data. Check RaySearch Laboratories AB (publ) (RAY-B) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
RaySearch Laboratories AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2025)
RaySearch Laboratories AB (publ)'s total assets of Skr2.03 Billion consist of 48.7% current assets and 51.3% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr407.30 Million | 20.5% |
| Accounts Receivable | Skr541.40 Million | 27.2% |
| Inventory | Skr22.00 Million | 1.1% |
| Property, Plant & Equipment | Skr447.30 Million | 22.5% |
| Intangible Assets | Skr558.70 Million | 28.1% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2003–2025)
This chart illustrates how RaySearch Laboratories AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see RaySearch Laboratories AB (publ) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: RaySearch Laboratories AB (publ)'s current assets represent 48.7% of total assets in 2025, a decrease from 74.1% in 2003.
- Cash Position: Cash and equivalents constituted 20.5% of total assets in 2025, up from 20.2% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 28.0% of total assets, an increase from 18.0% in 2003.
- Asset Diversification: The largest asset category is intangible assets at 28.1% of total assets.
RaySearch Laboratories AB (publ) Competitors by Total Assets
Key competitors of RaySearch Laboratories AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INVENTURUS KNOWLEDGE SO L
NSE:IKS
|
India | Rs36.06 Billion |
|
Waystar Holding Corp. Common Stock
NASDAQ:WAY
|
USA | $5.84 Billion |
|
DocCheck AG
XETRA:AJ91
|
Germany | €55.68 Million |
|
Kovo Healthtech Corp
V:KOVO
|
Canada | CA$6.64 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$92.19 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
RaySearch Laboratories AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.79 | 1.53 | 1.39 |
| Quick Ratio | 1.71 | 1.52 | 1.33 |
| Cash Ratio | 0.00 | 0.78 | 0.38 |
| Working Capital | Skr446.20 Million | Skr342.77 Million | Skr133.02 Million |
RaySearch Laboratories AB (publ) - Advanced Valuation Insights
This section examines the relationship between RaySearch Laboratories AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.14 |
| Latest Market Cap to Assets Ratio | 0.35 |
| Asset Growth Rate (YoY) | -4.7% |
| Total Assets | Skr1.99 Billion |
| Market Capitalization | $689.42 Million USD |
Valuation Analysis
Below Book Valuation: The market values RaySearch Laboratories AB (publ)'s assets below their book value (0.35x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: RaySearch Laboratories AB (publ)'s assets decreased by 4.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for RaySearch Laboratories AB (publ) (2003–2025)
The table below shows the annual total assets of RaySearch Laboratories AB (publ) from 2003 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr1.99 Billion ≈ $214.37 Million |
-4.74% |
| 2024-12-31 | Skr2.09 Billion ≈ $225.04 Million |
+7.09% |
| 2023-12-31 | Skr1.95 Billion ≈ $210.14 Million |
+4.09% |
| 2022-12-31 | Skr1.88 Billion ≈ $201.88 Million |
+7.87% |
| 2021-12-31 | Skr1.74 Billion ≈ $187.15 Million |
+35.34% |
| 2020-12-31 | Skr1.28 Billion ≈ $138.28 Million |
+1.64% |
| 2019-12-31 | Skr1.26 Billion ≈ $136.05 Million |
+14.37% |
| 2018-12-31 | Skr1.11 Billion ≈ $118.96 Million |
+20.80% |
| 2017-12-31 | Skr915.06 Million ≈ $98.48 Million |
+27.58% |
| 2016-12-31 | Skr717.25 Million ≈ $77.19 Million |
+48.04% |
| 2015-12-31 | Skr484.49 Million ≈ $52.14 Million |
+24.31% |
| 2014-12-31 | Skr389.75 Million ≈ $41.94 Million |
+30.28% |
| 2013-12-31 | Skr299.16 Million ≈ $32.19 Million |
+2.09% |
| 2012-12-31 | Skr293.03 Million ≈ $31.53 Million |
+12.27% |
| 2011-12-31 | Skr261.00 Million ≈ $28.09 Million |
+1.98% |
| 2010-12-31 | Skr255.93 Million ≈ $27.54 Million |
+9.79% |
| 2009-12-31 | Skr233.10 Million ≈ $25.09 Million |
+23.93% |
| 2008-12-31 | Skr188.09 Million ≈ $20.24 Million |
+8.58% |
| 2007-12-31 | Skr173.23 Million ≈ $18.64 Million |
+18.43% |
| 2006-12-31 | Skr146.27 Million ≈ $15.74 Million |
+36.47% |
| 2005-12-31 | Skr107.18 Million ≈ $11.53 Million |
+135.99% |
| 2004-12-31 | Skr45.42 Million ≈ $4.89 Million |
+47.67% |
| 2003-12-31 | Skr30.76 Million ≈ $3.31 Million |
-- |
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment co… Read more